Current Medical Diagnosis & Treatment, 2006 (Current Medical Diagnosis and Treatment)

Tierney, Lawrence M., McPhee, Stephen J., Papadakis, Maxine A.

Current Medical Diagnosis & Treatment, 45th Edition

H

H₁ receptor blocking drugs See Antihistamines

H₂ receptor blocking drugs

588–589

for dyspepsia

537

gastrin levels affected by

595

for gastroesophageal reflux disease

568

for NSAID gastritis

583

nutrients affected by

1260

for peptic ulcer disease

588–589

589

590

590

for stress gastritis

583

H63D mutation See also HFE gene

in hemochromatosis

676

677

H1069Q mutation, in Wilson's disease

678

H pylori infection See Helicobacter pylori infection

HAART regimens See Highly active antiretroviral therapy

Habitrol See Nicotine, for replacement therapy in smoking cessation

Habitual (recurrent) abortion

769

HACEK organisms, endocarditis caused by

1415

1419

Haemophilus

1422

1552

1553

aphrophilus, endocarditis caused by

1415

ducreyi

1433

influenzae

1422

immunization against

1305–1306

pneumonia caused by

248

251

254

1422

1553

in HIV infection/AIDS

1323

1422

parainfluenzae, endocarditis caused by

1415

Hair

excess of See Hirsutism

exclamation, in alopecia areata

144

loss of

144–145

drugs causing

145

148

Hair analysis, for drug detection

1083

Hair cells

chemical destruction of for vertigo

193

hearing loss caused by loss of

180

Hairy cell leukemia

511–512

1663

aplastic anemia differentiated from

497

rheumatic manifestations of

863

Hairy leukoplakia, in HIV infection/AIDS

216

217

1325

Halcion See Triazolam

Haldol See Haloperidol

Hallucinations/hallucinosis

alcoholic (organic)

1084

1085–1086

1092

in delirium

1092

intracranial mass lesions causing

1001

in Lewy body dementia

56

luminous, in migraine headache

975

in narcolepsy

1080

in schizophrenia/psychotic disorders

1058

substance-induced

1092

Hallucinogenic mushroom poisoning

1627

1629

1630

Hallucinogens

1627

Hallucinosis See Hallucinations/hallucinosis

Halobetasol

88

Halofantrine

1490

1494

1496

1497

resistance to

1492

Haloperidol

1059

1060

1060

adverse ocular effects of

178

for aggressive/violent behavior

1082

1093

for alcoholic hallucinosis

1086

antidepressant drug interactions and

1074

decanoate form of

1062

for delirium

59

1093

intravenous

1062

overdose/toxicity of

1060

1633

for Tourette's syndrome

1014

HAM See Human T cell lymphotropic/leukemia virus (HTLV), myelopathy of

Hamartomatous polyposis syndromes

636

Hamburger See Beef

Hamman-Rich syndrome (acute interstitial pneumonitis/AIP)

277

HAMP gene, in juvenile-onset hemochromatosis

676

Hampton's hump, in pulmonary embolism

281–282

Hand

burn injuries of, maintenance of function and

1598

in complex regional pain syndrome (reflex sympathetic dystrophy)

822

in immersion syndrome

1592

in Raynaud's disease/phenomenon

464

465

Hand dermatitis, vesiculobullous (pompholyx/dyshidrosis/dyshidrotic eczema)

111–112

Hand disinfection/washing, in infection control

1291

1292

Hand-foot-mouth disease

coxsackieviruses causing

204

1390

enterovirus 71 causing

1390–1391

herpetic stomatitis differentiated from

204

Hand movements (visual acuity)

151

Handgrip, heart murmurs affected by

329

P.1803

Hantaviruses/Hantaan virus

1378

hantavirus pulmonary syndrome caused by

1378

hemorrhagic fever caused by

1376

Haptoglobin

in hemolytic anemia

490

laboratory reference range for

1739

Harris-Benedict equation

1253

1281

Hartley-Dunhill operation

1140

Hashimoto's (chronic lymphocytic) thyroiditis

1136

1141

1143–1144

1146

HLA in

801

solitary thyroid nodule in

1120

thyroid antibodies in

1118

1143

1145

Hashish

1088

Hashitoxicosis

1146

HAV See Hepatitis A virus

Havrix See Hepatitis A vaccine

Hay fever See Allergic rhinitis

Hb See Hemoglobin

HbA₁ See Hemoglobin A₁/A_1a/A_1b/A_1c

HbA₂ See Hemoglobin A₂

HBcAg

653

antibody to (anti-HBc)

653

654

654

screening blood for

534

HbCO See Carboxyhemoglobin levels

HBeAg

653

654

654

659

antibody to (anti-HBe)

653

654

654

659

HbF See Hemoglobin F

HBIG See Hepatitis B immune globulin

HBsAg

653

653

654

antibody to (anti-HBs)

653

653

654

in hepatocellular carcinoma

682

maternal carrier state/transmission to newborn and

653

vaccination recommendations and

657

764

screening blood for

534

HBV See Hepatitis B virus

hCG See Human chorionic gonadotropin

HCO₃^- See Bicarbonate

Hct See Hematocrit

HCTZ See Hydrochlorothiazide

HCV See Hepatitis C virus

HDCV (human diploid cell) rabies vaccine

1314

1370–1371

HDL See High-density lipoproteins

HDV See Hepatitis D virus

Head injury

1019–1020

1020

headache associated with

977

hearing loss associated with

187

188

hypopituitarism and

1104

seizures associated with

980

vertigo associated with

191

Head lice

135

Head and neck cancer

chemotherapy of

1664

lymphoma

216

metastatic

216

smoking and

5

1646

1647

Head and neck surgery, antibiotic prophylaxis for

47

Head-up tilt table testing, in syncope evaluation

368

384

Headache

31–33

32

974–978

acupuncture for

1726

1728

acute

31–33

32

in acute mountain sickness

1604

cerebral arteriovenous malformations causing

997

in giant cell arteritis

846

977

hypertension and

32

425

in intracerebral/subarachnoid hemorrhage

32

978

995

from intracranial aneurysm leak

996

ocular disorders and

32

150

oral contraceptive use and

753

in pheochromocytoma

32

1174

in primary angiitis of central nervous system

851

in pseudotumor cerebri

1005

Health care providers See also Physician

HIV transmission risk and

1319

1333

relationship of with patient See Doctor–patient relationship

SARS transmission prevention and

1386

tuberculosis vaccination for

263

Health care proxy See Advance directives

Health maintenance/disease prevention

2–19

3

in elderly

54–55

Hearing, evaluation of

180–181

in elderly

51

52

Hearing aids/hearing amplification

181

compliance with use of

52

in recruitment

189–190

Hearing loss

180–181

aminoglycosides causing

1573

auditory tube dysfunction causing

180

183

autoimmune

189

conductive

180

confusion/dementia and

57

in elderly (presbyacusis)

51

52

180

187–188

in endolymphatic hydrops (Meniere's syndrome)

191

glomus tumors causing

187

head trauma causing

187

188

hereditary

188–189

in HIV infection/AIDS

194

in labyrinthitis

191

neural

180

eighth nerve lesions causing

180

noise trauma causing

180

181

187

188

ossicular chain disruption causing

180

in otitis media

185

in otosclerosis

180

186

ototoxicity and

188

physical trauma causing

187

188

sensorineural

180

sensory

180

187–189

sudden

188

tinnitus and

189

vertigo and

190

vestibular schwannoma (acoustic neurinoma) causing

180

193

1000

Hearing rehabilitation

181

Heart

312–418

examination of

in cardiac failure

389

in cardiovascular screening of athletes

418

in myocardial infarction

356

holiday

375

in hypertension

426

myxedema

1132

1133

Starling's law of

386

systemic diseases affecting

413–414

traumatic injury of

414

Heart block See Atrioventricular (heart) block

Heart disease

312–418

anthracycline use and

1685

appearance of patients with

313–314

in athletes, screening for

417–418

carcinoid

413–414

611

cardiomyopathies

400–405

401

in hyperthyroidism

1137

1142

peripartum

417

778

in Chagas' disease

399

1465

1466

1467

chest pain in

312

Chlamydia pneumoniae in

446

1442

cholesterol/lipoproteins in

339

340

screening tests for levels of

1244–1247

1245–1246

coenzyme Q₁₀ for

1721

1722

conduction disturbances

382–385

congenital

318–325

pregnancy and

416

777–778

coronary (arteriosclerotic/ischemic)

339–366

in diabetes mellitus

1225

diagnosis of

316–318

dyspnea in

23–24

312–313

endocarditis prophylaxis and

1416

1416

1417

estrogen replacement therapy and

341

761

1187

1188

functional classification of

313

pregnancy and

778

778

homocysteine/hyperhomocysteinemia in

10–11

341

1706–1707

hypertension and

314

424–425

hyperthyroidism and

389

1132

1137

1141–1142

hypertriglyceridemia and

1252

in hypothyroidism

1132

in Lyme disease

408

1458

1461

1461

in Marfan's syndrome

414

1707

1708

metabolic syndrome (syndrome X/CHAOS) and

339

myocarditis

398–400

399

neoplastic

413

pericardial disorders and

407–410

pleural effusion in

297

cardiac failure and

300

390

in polyarteritis nodosa

845

pregnancy and

416–417

777–778

778

preoperative evaluation/management of patient with

36–41

36

37

38

39

415

prevention of

5–12

340–342

antihypertensive therapy in

11–12

aspirin in

341

exercise/activity and

12

341

hyperhomocysteinemia prevention and

10–11

341

1707

lipid disorder prevention/management and

8–10

341

cholesterol screening and

1244–1247

1245–1246

in women and elderly

1246

1247

smoking cessation and

5–8

6–7

8

9

10

11

339

pulmonary (cor pulmonale)

412

pulmonary hypertension and (primary pulmonary hypertension)

290

410–411

411

rate and rhythm disturbances

366–382

rheumatic/rheumatic fever and

405–407

scleroderma and

838

signs of

313–316

spondylitic

852

surgery in patient with

414–415

symptoms of

312–313

systemic disorders and

413–414

in systemic lupus erythematosus

413

834–835

P.1804

traumatic

414

valvular

325–339

326–328

Heart failure See Congestive heart (cardiac) failure

Heart-lung transplant, for cystic fibrosis

246

Heart murmurs

315

326–327

in aortic regurgitation

326–327

335

in aortic stenosis

326–327

333

atrial myxoma causing

413

in atrial septal defect/patent foramen ovale

321

bedside maneuvers/interventions affecting

329

in cardiac failure

389

in cardiomyopathy

403

in endocarditis

1415

1416

in hypertension

426

in mitral regurgitation

326–327

330

in mitral stenosis

325–329

326–327

in mitral valve prolapse

331

in myocardial infarction

356

in patent ductus arteriosus

324

during pregnancy

416

in pulmonary stenosis

318–319

in rheumatic carditis

405

in tricuspid regurgitation

326–327

337

in tricuspid stenosis

326–327

in ventricular septal defect

322

Heart rate

314

disturbances of

366–382

normal

314

during pregnancy

416

in pulmonary embolism

282

variability in, in arrhythmia evaluation

367

Heart rhythm, disturbances of

366–382

Heart sounds

315

in atrial septal defect

321

in cardiac failure

389

in cardiomyopathy

403

in hypertension

426

in myocardial infarction

356

in pregnancy

416

in pulmonary embolism

282

in pulmonary stenosis

320

in pulmonic regurgitation

338

in tetralogy of Fallot

323

in valvular heart disease

326

Heart transplantation, for cardiac failure

396

Heart valves See Prosthetic heart valves; Valve replacement; Valvular heart disease

Heartburn (pyrosis)

536

563–564

566

Heartworm infection (dirofilariasis)

1522

Heat

disorders caused by exposure to

1592–1595

cholinergic urticaria

121

122

erythromelalgia

466

miliaria

119–120

reduction/removal of

27

1593

for heat exposure syndromes

1593

1594

Heat cramps

1593

Heat exhaustion

1593–1594

Heat rash

119–120

Heat stroke

1594–1595

Heat syncope

1593

Heat therapy, for rheumatoid arthritis

829

Heavy chain disease

798

Heavy metals See also specific type

adverse ocular effects of

179

overdose/poisoning caused by

1611

tubulointerstitial disease caused by

926

927

Hebephrenic (disorganized) schizophrenia

1056–1057

Heberden's nodes

808

Hectoral See Doxercalciferol

Heel, plantar hyperkeratosis of

129

Hegar dilators, for vaginismus

1054

Heimlich maneuver

for foreign body

214

in near drowning

1602

Heinz bodies

in glucose-6-phosphate dehydrogenase deficiency

492

unstable hemoglobins and

495

Helical (spiral) CT See Computed tomography; Spiral (helical) CT

Helicobacter pylori infection

1553

dyspepsia and

536

537

eradication therapy for

589

590

cancer incidence and

597

dyspepsia management and

537

gastric/MALT lymphoma and

599

gastritis management and

584

peptic ulcer management and

589

590

NSAID-induced ulcers and

587

590

590

591

perforation prevention and

594

rebleeding prevention and

592–593

gastric/MALT lymphoma and

584

598–599

1644

gastritis

584–585

gastric cancer and

584

597

1644

peptic ulcer disease and

584

586

588

589

590

refractory

591

resistant strains of

589

testing for

584

588

597

in dyspepsia

536

laboratory reference range for

1739

Heliotrope rash, in dermatomyositis

840

Helium-oxygen mixture (Heliox)

for asthma

237

for smoke inhalation

293

Heller cardiomyotomy, for achalasia

580

HELLP syndrome

771

Helmet cells, in microangiopathic hemolytic anemia/thrombotic thrombocytopenic purpura

497

521

Helminthic infections

1501–1535

cestodes causing

1508–1515

cholangiocarcinoma and

692

1506

eosinophilic pulmonary syndromes caused by

280

1518

1522–1523

nematodes (roundworms) causing

1515–1535

trematodes (flukes) causing

1501–1508

Helper-inducer T cells See CD4 T cells

Helvella (gyromitrin) mushroom poisoning

1629

1630

Hemangioblastoma, cerebellar

999

1000

paraneoplastic syndromes associated with

1696–1697

Hemangioma, cavernous, of liver

683

Hemarthroses, in hemophilia

526

Hematemesis

in erosive/hemorrhagic gastritis/gastropathy

582

in gastrointestinal bleeding

551

557

in Mallory-Weiss syndrome

572

in peptic ulcer disease

592

Hematin, for porphyria

1025

1704

Hematochezia

in inflammatory bowel disease

555

in lower gastrointestinal bleeding

554

555

in peptic ulcer disease

592

in rectal cancer

638

in upper gastrointestinal bleeding

551

555

Hematocrit See also specific disorder

in anemia

481

in hemolytic anemia

490

495

laboratory reference range for

1739

in polycythemia

500

500

501

in sickle cell syndromes

493

Hematogenous osteomyelitis

858

859

Hematologic disorders

481–535

anemias

481–498

cancer-related

1697

1698

chloramphenicol causing

1572

hemostasis disorders

518–531

hypercoagulable states

531–533

531

neoplastic

leukemias/myeloproliferative disorders

499–512

499

500

lymphomas

512–518

neutropenia

498–499

499

preoperative evaluation/management of patient with

36

43–44

radiation exposure and

1600

in renal failure

910

Hematoma

auricular (cauliflower ear)

181

perianal, thrombosed hemorrhoid causing

645

septal, in nasal trauma

199–200

subperichondrial

200

Hematometra, in endometrial carcinoma

738

Hematopoiesis, ineffective, in myeloplastic syndromes

504

Hematopoietic progenitor cell transplantation

802–803

Hematopoietic stimulating factors See Filgrastim; Growth factors; Sargramostim

Hematospermia

932

Hematuria

896

897

931–932

935–936

in bladder cancer

936

967

by dipstick

897

935

evaluation of

897

935–936

in focal segmental glomerular sclerosis

922

in glomerulonephritis

906

in Goodpasture's syndrome

293

hemorrhagic cystitis and

33

1683

in IgA nephropathy

917

in polycystic kidney disease

928

in renal cell carcinoma

936

969

970

in schistosomiasis

1502

1503

synpharyngitic

917

in ureteral and renal pelvis cancer

936

969

in urinary stone disease

936

944

Hemianopia See also Visual field defects

stroke causing

993

Hemiplegia See also Paralysis

stroke causing

991

993

995

996

Hemobilia

552

Hemoccult See Fecal occult blood testing

Hemochromatosis

676–677

cirrhosis and

669–670

676

677

genetic/prenatal testing for

677

hepatocellular carcinoma and

682

hyperpigmentation in

1100

hypopituitarism caused by

1105

nonalcoholic fatty liver disease and

667

Hemoclips, for bleeding peptic ulcer

593

Hemodialysis

912

for hyperkalemia

876

877

P.1805

in older adult

930

pigmentation abnormalities associated with

1100

for poisoning/drug overdose

1613

1613

with lithium

1077

1613

with methanol or ethylene glycol

1613

1628

with salicylates

1613

1634

with theophylline

1613

1637

with valproic acid

1613

1619

for renal failure

912

coagulopathy and

910

Hemodynamic status

in COPD

239

gastrointestinal bleeding and

552

in myocardial failure

386

in myocardial infarction

357

357

Hemoglobin

acute tubular necrosis/renal failure and

903–904

in anemia

481

glycated/glycosylated See Hemoglobin A₁/A_1a/A_1b/A_1c

laboratory reference range for

1739

postoperative complications and

43

unstable

495

Hemoglobin A

484

in beta thalassemia syndromes

484–485

485

in sickle cell syndromes

494

494

Hemoglobin A₁/A_1a/A_1b/A_1c (glycated/glycosylated hemoglobin)

in diabetes mellitus

1199–1200

1202

1203

1204

1205

1218

1220

pregnancy and

777

laboratory reference range for

1739

Hemoglobin A₂

484

in beta thalassemia syndromes

484–485

485

laboratory reference range for

1739

in sickle cell syndromes

494

Hemoglobin AS genotype (sickle cell trait)

494

494

Hemoglobin C disorders

494–495

pregnancy and

775

Hemoglobin electrophoresis

laboratory reference range for

1739

in sickle cell syndromes

493–494

494

Hemoglobin F (fetal hemoglobin)

484

in beta thalassemia syndromes

484–485

485

laboratory reference range for

1739

in sickle cell syndromes

494

494

Hemoglobin H/hemoglobin H disease

484

484

485

485–486

486

Hemoglobin S

493

494

494

Hemoglobin saturation See SaO₂

Hemoglobin SC disease

495

proliferative retinopathy in

168

Hemoglobinemia, in hemolytic anemia

490

Hemoglobinuria

897

935

in hemolytic anemia

490

iron deficiency and

482

in malaria

1497

paroxysmal nocturnal

491–492

Hemojuvelin, in juvenile-onset hemochromatosis

676

Hemolytic anemias/hemolysis

490

491

acute tubular necrosis and

903–904

autoimmune

495–496

in cold agglutinin disease

496

in glucose-6-phosphate dehydrogenase deficiency

492

in hemoglobin C disorders

494–495

in hemoglobin H disease

485

in hereditary spherocytosis

490

491

in hypophosphatemia

881

882

microangiopathic

490

497

521

in disseminated intravascular coagulation (DIC)

530

hemolytic-uremic syndrome and

522

thrombotic thrombocytopenic purpura and

497

521

521

in paroxysmal nocturnal hemoglobinuria

491

in sickle cell syndromes

493

in thrombotic thrombocytopenic purpura

521

unstable hemoglobins and

495

Hemolytic crises, in sickle cell disease

493

Hemolytic disease of newborn, prevention of

783

Hemolytic streptococcus See specific type under Group

Hemolytic transfusion reactions

533–534

acute tubular necrosis and

904

Hemolytic-uremic syndrome

522–523

E coli O157:H7 causing

522

1300

1427

Hemopericardium

414

Hemophilia A

525

526–527

Hemophilia B

528

Hemoptysis

220

in bronchiectasis

244

in Goodpasture's syndrome

293

in lung cancer

220

267

in pulmonary embolism

282

in tuberculosis

257

Hemorrhage See specific type or structure affected and Bleeding

Hemorrhagic conjunctivitis, acute, enterovirus 70 causing

1390

Hemorrhagic cystitis

33

adenovirus causing

1386–1387

chemotherapy-induced

1683

mesna for

1677

1683

Hemorrhagic fevers

1371

1376–1377

dengue

1377

Hemorrhagic (erosive) gastritis See Gastritis

Hemorrhagic pleural effusion

300

malignant

1693

Hemorrhagic pneumonia, in leptospirosis

1456

Hemorrhagic shock See Hypovolemic shock

Hemorrhoidectomy

644–645

Hemorrhoids

643–645

bleeding and

555

pruritus ani caused by

133

134

thrombosed

645

Hemosiderin

481

accumulation of See also Hemochromatosis

urine

laboratory reference range for

1739

in paroxysmal nocturnal hemoglobinuria

491

Hemosiderosis

idiopathic pulmonary

293

transfusional, in thalassemia

485

486

Hemostasis, disorders of

518–531

Hemosuccus pancreaticus

552

Hemothorax

300

302–303

Hemotympanum

184

187

Henderson-Hasselbalch equation

885

Henoch-Sch nlein (anaphylactoid) purpura

850

917–918

917

Hep A See Hepatitis A vaccine

Hep B See Hepatitis B vaccine

Hepacare See Hepatitis B vaccine

Hepar lobatum, in syphilis

1450

Heparin/low-molecular weight heparin

for acute coronary syndromes

352

353

for arterial embolism

461

for deep venous thrombosis/pulmonary embolism

in prevention

284

286

287

471

in treatment

284–289

288

472

for disseminated intravascular coagulation

531

in meningococcal meningitis

1422

for hypercoagulability

532

hyperkalemia and

876

for myocardial infarction

352

353

thrombolytic therapy and

359

for stroke

993

994

thrombocytopenia caused by

520

for transient ischemic attacks

990

Heparin-induced thrombocytopenia

520

Hepatic abscess

amebic

1468–1472

1471

pyogenic

680–681

Hepatic adenoma

683–684

oral contraceptive use and

683

753

Hepatic artery aneurysm

450

Hepatic biopsy See Liver, biopsy of

Hepatic coagulopathy

528–529

in cirrhosis

671

Hepatic cysts, hydatid

1513

1514

1515

Hepatic disease See Liver, disorders of

Hepatic encephalopathy

672

bleeding esophageal varices and

575

672

in cirrhosis

669

672

in hepatic failure

658

659

protein-restricted diet for

672

1279

Hepatic (liver) failure

658–659

acetaminophen causing

658

659

666

1616

acute

658–659

in amatoxin-type mushroom poisoning

1629

1630

antimicrobial dosage adjustment and

1558–1559

Hepatic fibrosis

drugs/toxins causing

666

in fatty liver disease

668

Hepatic hydrothorax

671

Hepatic steatosis See Fatty liver

Hepatic vein obstruction (Budd-Chiari syndrome)

678–680

Hepatitis

alcoholic

663–665

autoimmune

662–663

drugs/toxins causing

666

erythromycin causing

1569

postoperative complications associated with

43

radiation exposure and

1600

viral

652–658

chronic

657–658

659–662

postoperative complications associated with

43

cirrhosis and

654

657

659–660

669

coxsackieviruses causing

1390

in drug users

653

654

655

1298

hepatic failure and

658

659

in HIV infection/AIDS

655

660

1326

liver cancer and

653

657–658

659

681

682

683

1644

in liver transplant patients, adenoviruses causing

1387

non-ABCDE

652

transfusion-associated

534

652

653

654–655

type A

652–653

652

prevention of/immunization against

656–657

1305–1306

1307–1309

1312

for travelers

656

1312

1314

P.1806

type B

653–654

653

654

acupuncture in transmission of

1724

arthritis in

858

cancer associated with

653

659

682

683

1644

chronic

653

654

654

657

659–660

660–661

cirrhosis and

653

659–660

669

delta agent (hepatitis D) and

654

660

HIV infection/AIDS and

660

1326

maternal carrier state/transmission to newborn and

653

764

vaccination recommendations and

657

764

1311

polyarteritis nodosa and

845

prevention of/immunization against

657

1305–1306

1307–1309

1311

for travelers

1313–1314

transfusion in transmission of/screening blood for

534

653

type C

654–655

655

acupuncture in transmission of

1724

arthritis in

858

cancer associated with

681

682

683

1644

prevention of

1649

chronic

657

660

661–662

cirrhosis and

660

669

cryoglobulinemia in

655

850

924

HIV infection/AIDS and

655

660

1326

maternal carrier state/transmission to newborn and

655

764

renal disease and

924

thyroiditis and

1131

1144

transfusion in transmission of/screening blood for

654–655

type D

654

chronic

660

662

hepatitis B and

654

660

type E

655

in pregnancy

655

657

type G

655

Hepatitis A and B vaccine

657

1312

Hepatitis A immune globulin

656

during pregnancy

767

Hepatitis A vaccine

656–657

1305–1306

1307–1309

1312

in HIV infection/AIDS

1308

during pregnancy

767

1308

for travelers

656

1312

1314

Hepatitis A virus

652–653

652

Hepatitis B core antigen (HBcAg)

653

antibody to (anti-HBc)

653

654

654

659

screening blood for

534

Hepatitis B e antigen (HBeAg)

653

654

654

659

antibody to (anti-HBe)

653

654

654

659

Hepatitis B immune globulin

657

for infants born to HBsAg-positive mothers

657

1311

Hepatitis B surface antigen (HBsAg)

653

653

654

antibody to (anti-HBs)

653

653

654

in hepatocellular carcinoma

682

maternal carrier state/transmission to newborn and

653

vaccination recommendations and

657

764

1311

screening blood for

534

Hepatitis B vaccine

657

1305–1306

1307–1309

1311

in cancer prevention

657

683

1649

in HIV infection/AIDS

4

1308

1332

for newborn/pregnant patient

657

764

1308

1311

after rape/sexual assault

760

1297

for travelers

1313–1314

Hepatitis B virus

653

Hepatitis B virus DNA

653

654

659

Hepatitis C virus

654

screening blood for

534

654

Hepatitis C virus RNA

655

655

660

Hepatitis D virus (delta agent)

654

Hepatitis D virus RNA

654

Hepatitis E virus (HEV)

652

655

Hepatitis G virus (HGV)

652

655

Hepatoblastomas, in familial adenomatous polyposis

635

Hepatocellular carcinoma

681–683

cirrhosis and

657

670

681–682

hepatitis and

653

657–658

659

681

682

683

1644

paraneoplastic syndromes associated with

1696–1697

polyprenoic acid in prevention of

1649

Hepatocellular disease See also Cirrhosis; Liver, disorders of

jaundice in

649

650

Hepatocyte nuclear factor 1a, hepatic adenomas and

684

Hepatojugular reflux

314

389

Hepatolenticular degeneration See Wilson's disease

Hepatomas, polyprenoic acid in prevention of

1649

Hepatomegaly

in cardiac failure

389

in cirrhosis

669

in hairy cell leukemia

511

in myelofibrosis

503

Hepatopathy, ischemic

680

Hepatopulmonary syndrome

673

Hepatorenal syndrome

671–672

Hepatosplenic/hepatic candidiasis

1537

Hepatotoxicity

665–666

of acetaminophen

658

659

666

1616

1616

antimicrobial dosage adjustment and

1558–1559

of erythromycin

1569

of herbal supplements

1711

kava

1717

of methotrexate

831

of tetracycline

1571

of thiazolidinediones

1210

Hepcidin, in juvenile-onset hemochromatosis

676

HER-1 receptor, drugs blocking, in cancer treatment

1699

HER-2/neu oncogene

dendritic cells loaded with, in cancer treatment

1700

drugs blocking

1699

overexpression of

in breast cancer

717

719

720

720

1641

1643–1644

trastuzumab treatment and

722

1643–1644

1667

1679

1698

cancer vaccine development and

1700

in prostate cancer

1644

Herald patch, in pityriasis rosea

99

“Herbal ecstasy” (ephedrine)

1618

1711

Herbal medicines

1709

1710–1719

1711

1712–1713

advice to patients using

1711

in cancer therapy

1702

epidemiology of use of

1710

hepatic failure and

658

product formulations/standardization and

1710–1711

quality assurance and

1710

regulatory issues regarding

1710

safety of

1711

Herbicide poisoning See Pesticide poisoning

Herceptin See Trastuzumab

Hereditary angioedema

122

Hereditary hearing loss

188–189

Hereditary motor and sensory neuropathy (HMSN), types I to IV

1024

Hereditary nonpolyposis colorectal cancer (HNPCC)

636–637

1643

Hereditary polymorphous light eruption

140

Hereditary spherocytosis

490–491

Hernias

hiatal, gastroesophageal reflux and

565

surgery for, antibiotic prophylaxis for

47

vaginal (genital prolapse)

741

Herniated nucleus pulposus See Nucleus pulposus, herniation of

Herniation syndromes, space-occupying tumors causing

1001

1002

Heroin

1086

1087

acupuncture for cessation of use of

1729

overdose/toxicity of

1631

Herpangina

1389

herpetic stomatitis differentiated from

204

Herpes genitalis

108–109

1350

during pregnancy/neonatal infection

778–779

1351

1353

Herpes (pemphigoid) gestationis

127

Herpes labialis

1350

Herpes simplex infection

108–109

1350–1354

acyclovir prophylaxis/treatment and

108–109

1290

1336

1351

1352

1353

1586–1587

anorectal involvement and

645

Bell's palsy and

1030

1351

1354

decubitus ulcers and

141

disseminated/generalized

1351

1354

dermatitis in (eczema herpeticum)

96

108

1351

1355

encephalitis

1351

1354

erythema multiforme associated with

122

1351

1354

esophagitis in

571

1351

1354

gladiatorum

108

in HIV infection/AIDS

1327

1336

1350

1353

esophageal

571

1351

1354

keratitis

158

1351

1353

during pregnancy/neonatal infection

778–779

1351

1353

stomatitis/gingivostomatitis in

108

204

treatment/prevention of

1351–1354

type 1

108

1350–1354

type 2

108

1350–1354

Herpes zoster (shingles)

109–110

1354–1358

eye involvement and

110

facial paralysis in (Ramsay Hunt syndrome)

194

1356

in HIV infection/AIDS/immunocompromised host

1327

1336

1356

1357

neuralgia after

110

979

1357

1358

during pregnancy

780–781

Herpes zoster ophthalmicus

110

159

Herpesviruses

1350–1362

Herpetic stomatitis/gingivostomatitis

108

204

P.1807

Herpetic whitlow

108

1350

Herplex See Idoxuridine

Hesitancy, urinary

932

HESX1 gene mutation, in pituitary hormone deficiency

1104

Heterophil antibody tests, in mononucleosis

1359

Heterotopic pregnancy

770

HEV See Hepatitis E virus

Hexosaminidase deficiency, in juvenile spinal muscular atrophy

1022

HFE gene

in alcoholic liver disease

664

in cirrhosis

670

in hemochromatosis

676

in nonalcoholic fatty liver disease

667

hGH See Human growth hormone

HGV See Hepatitis G virus

HHV See Human herpesviruses

5-HIAA See 5-Hydroxyindoleacetic acid

Hiatal hernia, gastroesophageal reflux and

565

Hib vaccine

1305–1306

in HIV infection/AIDS

4

Hibernation, myocardial

342–343

Hiccups

540–541

HIDA scan, in cholecystitis

686

Hidradenitis suppurativa

138

HIFU See High-intensity focused ultrasound

High-altitude bronchitis

1605

High-altitude encephalopathy

1605

High-altitude pulmonary edema

1604–1605

High-altitude retinopathy

1605

High blood pressure See Hypertension

High-calcium diet

1279

High-carbohydrate diet, in porphyria

1025

1703–1704

High-density lipoproteins

1240

atherogenesis/coronary heart disease and

339

340

1240–1241

1241–1242

in diabetes mellitus

1201

diet affecting

1247–1248

estrogen replacement affecting

1187

laboratory reference range for

1739

pioglitazone affecting levels of

1210

raising levels of

8–10

341

1242

1247

fibric acid derivatives for

1250

niacin for

1249

1273–1274

rosiglitazone affecting levels of

1210

screening tests for levels of

1244–1247

1245–1246

High dose chemotherapy, with bone marrow/hematopoietic progenitor cell (stem cell) transplantation

802–803

1661

1680

High-fiber diet See Fiber, dietary

High-intensity focused ultrasound (HIFU), for benign prostatic hyperplasia

961

High-output heart failure

386

High-potassium diet

1279

High-resolution computed tomography (HRCT), in solitary pulmonary nodule

265–266

Highly active antiretroviral therapy (HAART)

1334

CMV retinitis and

1360

in cytomegalovirus disease control

570

1360

1361

gynecomastia and

1100

nephropathy progression and

923

opportunistic infection prophylaxis and

1334

1346

1347

during pregnancy

776

progressive multifocal leukoencephalopathy and

1375

varicella zoster immune restitution disease and

1357

Hilar adenopathy, in sarcoidosis

279

Hill's sign

335

Hip arthroplasty

810

864

Hip fracture, falls in elderly and

16

61

Hip protectors, fracture prevention and

16

61

Hirschsprung's disease

542

in multiple endocrine neoplasia

1192

Hirsutism

1170–1172

in persistent anovulation (polycystic ovary syndrome)

746

747

1170

1171

His-ventricular interval, long

383

Histamine

in bronchial provocation testing for asthma

224

227

drugs blocking receptors for See Antihistamines; H2 receptor blocking drugs

Histiocytosis, Langerhans cell

1104

1107

Histoplasma capsulatum (histoplasmosis)

1538–1539

bone and joint involvement in

860

in HIV infection/AIDS

1538

Histrionic (hysterical) personality disorder

1055

HIT See Heparin-induced thrombocytopenia

HIV/HIV-1

1320

blocking entry of into cells

1342

drug resistance and

1336

1339

1343

1343–1345

1344

1345

monkeypox immunization and

1388

screening blood for antibody to

534

1319

1331

serologic tests in identification of

1349

HIV-2

1320

HIV-associated cognitive/motor complex (AIDS dementia complex)

1092

1324

HIV-associated nephropathy

923

HIV infection/AIDS

1317–1348

acupuncture in transmission of

1724

adrenal insufficiency in

1327

anal cancer and

648

1329

arthritis in

857

1325

aspergillosis in

194

217

1544

autoimmunity in

1320

bacillary angiomatosis in

1328

1434

bartonellosis in

1434

biliary disease in

1326

blastomycosis in

1545

breast feeding in transmission of

776

1333

campylobacter-like organisms causing disease in

1429

cancer associated with

1328–1329

1334

1336

1644

candidiasis in

esophageal

1322

1326

1336

oral (thrush)

203

216–217

1322

1325–1326

1347

vulvovaginal

1329

1336

1347

CD4 T cells in See CD4 T cells

CDC definitions and

1317

1318

cerebral lymphoma in

1000

1003

1324

1328

cervical intraepithelial neoplasia/cervical cancer in

735

1329

Chagas' disease reactivation and

1466

cholecystitis in

1326

clinical findings in

1321–1329

1321

coccidial and microsporidial infection in

1475–1478

coccidioidomycosis in

1539

counseling and

1331

1332–1333

postexposure prophylaxis and

1333

cryptococcosis/cryptococcal meningitis in

1003

1324

1335

1543

prevention of

1347

1543

cryptosporidiosis in

1326–1327

1476–1477

cytomegalovirus infections in

168

546

570–571

1323

1325

1335

1360–1361

esophagitis

570–571

1360

prophylaxis of

1347

retinitis

168

1325

1360

1361

dementia associated with

1092

1324

diarrhea/enterocolitis in

545

546

549

1326–1327

1475–1478

differential diagnosis of

1330–1331

drug use and

1298

1319

1331

postexposure prophylaxis and

1333

endocrinologic manifestations of

1327

Epstein-Barr virus infection in

1359

esophagitis in

570–571

1322

1326

etiology of

1320

fever/FUO and

27

1286

1287

1321

folliculitis and

119

1327

gastrointestinal manifestations of

1326–1327

gastropathy in

1327

gynecologic manifestations of

1329

gynecomastia in

1100

hairy leukoplakia in

216

217

1325

health care maintenance for patients with

1331–1333

1332

hemophilia and

526

hepatic disease/hepatitis in

655

660

1326

herpes simplex infection in

1327

1336

1350

1353

acyclovir prophylaxis and

1351

esophagitis

571

1351

1354

herpes zoster and

1327

1336

1356

1357

histoplasmosis in

1538

Hodgkin's disease in

1328–1329

1644

hyperkalemia in

876

hyponatremia in

870–871

immunization recommendations in

4

1308

immunodeficiency state of

1320

incidence/prevalence of

1319

infections in

1289

Opportunistic infections

CD4 T cell levels and

1321

1321

prevention of

1331–1333

1332

1346–1347

1346

treatment of

1334

1335–1336

inflammatory reactions in

1329

influenza vaccination and

4

1308

1310

1384

intracranial mass lesions in

1003

Kaposi's sarcoma in

132

216

217

1320

1323

1328

1336

1644

laboratory findings in

1329–1330

1330

lactic acidosis and

887

leishmaniasis coinfection and

1481

lymphadenopathy in

215

217

auditory tube dysfunction/serous otitis media and

194

lymphoma in

216

1000

1003

1323

1328

1335

1644

MAC infections in

1335

1437

prevention of

1347

1437

malabsorption in

1327

measles in

1363

vaccination against

4

1304

1308

1332

1364

mental status changes in See HIV-associated cognitive/motor complex

MMR vaccination and

4

1304

1306

1308

molluscum contagiosum in

129

1327

1388

P.1808

myelopathies in

1324

myocarditis in

399

myopathy in

1325

neck findings in

217

nephropathy in

923

neurologic manifestations of

1320

1324–1325

neuropathy

1026

1325

ocular manifestations of

168

oral lesions in

216–217

1325–1326

otolaryngologic manifestations of

216–217

otologic manifestations of

194

paranasal sinuses in

217

1323–1324

pathogenesis of

1320

pathophysiology of

1320

Penicillium marneffei infection in

1546

perinatal transmission of

1319

1333

breast feeding and

776

1333

pharyngeal lesions in

216–217

pneumonia in

256

1322–1323

1334

1541

1542

CD4 T cell count and

1321

1321

1323

1346

1541

D_LCO (diffusing capacity for carbon monoxide) in

223

1323

immunization against See Pneumococcal vaccine

pneumonitis in, nonspecific interstitial

1323

poliomyelitis vaccine in

4

in pregnancy

776

1333

prevention of

4

1331–1334

1332

condoms for

4

1331

postexposure prophylaxis and

1333

prognosis of

1347–1348

progressive multifocal leukoencephalopathy in

1324–1325

1375

psoriasis in

857

1328

pulmonary manifestations of

256

1322–1323

D_LCO (diffusing capacity for carbon monoxide) and

223

reactive arthritis/Reiter's syndrome and

855

857

retinitis in

168

1325

rheumatic manifestations of

857

1325

rubella vaccination and

4

1306

1308

scabies in

134

135

sclerosing cholangitis in

691

1326

screening for See HIV testing

seizures in

980

sinusitis in

217

1323–1325

skin disorders in

1327–1328

sporotrichosis in

1546

staging, oral lesions in

216

strongyloidiasis in

1529

sulfonamide side effects and

1576

suppurative thyroiditis in

1145

syndrome of inappropriate ADH secretion (SIADH) and

871

syphilis and

1332

1443

1446

1447

1452

syphilis tests affected by

1332

1452

systemic complaints associated with

1321–1322

T cells in See CD4 T cells

toxoplasmosis in

1003

1324

1335

1499

1499–1500

1500

prophylaxis of

1333

1347

1500

transient ischemic attacks and

989

transmission of

1318–1320

acupuncture and

1724

blood screening/blood treatment and

534

1319

1331

to fetus/newborn

776

1333

health care providers and

1319

1333

prevention of

4

1331–1334

condoms for

4

1331

postexposure prophylaxis for

1333

rape/sexual assault and

759

1297

1298

risk/risk assessment of

1318–1319

transfusions and

534

1319

1331

treatment of

1334–1347

antiretroviral therapy

1334–1345

1337–1338

1343

1344

1345

hematopoietic stimulating factors

1346

opportunistic infections/malignancies and

1334

1335–1336

during pregnancy

776

1333

tuberculosis and

259

261

tuberculin skin test in

259

259

1323

1331–1332

tuberculosis in

257

258

chemoprophylaxis/prevention and

263

1332

1347

intestinal involvement in

614

peritoneal involvement and

562

treatment of

261

uveitis in

162

vaccine development and

1331

varicella zoster virus infection and

1327

1336

1356

1357

VDRL test in

1332

venereal warts in

645

646

weight loss in

1321–1322

Wernicke's encephalopathy in

1017

in women

1319

HIV testing

1329–1330

1329

in blood screening

534

1319

1331

after needle-stick

1319

1333

pre- and posttest counseling and

1331

in pregnancy

766

in prenatal care

764

after rape/sexual assault

759

1297

in syphilis patients

1332

1446

1447

HIV viral load tests

1330

1330

antiretroviral therapy initiation/monitoring and

1336

1339

laboratory reference range for

1739

Hives See Urticaria

Hivid See Zalcitabine

HJV gene, in juvenile-onset hemochromatosis

676

HLA See Human leukocyte antigens

HLA typing See Human leukocyte antigens (HLA), typing

HM See Hand movements

hMG See Human menopausal gonadotropins

HMG-CoA reductase inhibitors See Statin drugs

hMLH1 gene, in hereditary nonpolyposis colorectal cancer

636

HMS See Medrysone

hMSH2/hMSH6 genes, in hereditary nonpolyposis colorectal cancer

636

HMSN See Hereditary motor and sensory neuropathy

HNPCC See Hereditary nonpolyposis colorectal cancer

Hoarseness

209

benign laryngeal tumors causing

210

contact ulcers causing

210

gastroesophageal reflux and

210

566

laryngeal leukoplakia causing

210

laryngeal papillomas causing

209

laryngitis causing

210

in squamous cell carcinoma of larynx

211

vocal cord nodules and

210

vocal cord paralysis causing

213

Hodgkin's disease

514–515

1663

Epstein-Barr virus in

1360

fever caused by

1287

in HIV infection/AIDS

1328–1329

1644

secondary malignancies and

1645

Hog

1088

Holiday heart

375

Hollenhorst plaques

456

Holosystolic murmurs

315

Holter monitoring See Ambulatory electrocardiographic monitoring

Homans' sign, in deep venous thrombosis/pulmonary embolism

282

471

Home environment, of elderly patients, falls and

60

61

Home oxygen therapy

240–242

240

Homeopathy

1729–1732

1731

Homeostenosis See also Age/aging

Homocysteine

elevated serum levels of, in coronary heart disease/occlusive arterial disease

10–11

341

1706–1707

laboratory reference range for

1739

Homocystinuria

1706

Homogentisic acid oxidase, deficiency of in alkaptonuria

1704

Homonymous field defects

150

stroke causing

991

993

“Honeycomb lung,” in interstitial (diffuse parenchymal) lung disease

275

Hookworm disease

1524–1526

cutaneous larva migrans

1519

eosinophilic pulmonary syndromes and

280

Hordeolum

154

Horizontal diplopia

152

Hormone receptor sites, in breast cancer

716–717

in male

727

prognosis and

720

724

treatment and

716–717

719

720

721–722

1670

1679

Hormone replacement therapy (HRT) See Estrogen (hormone) replacement therapy

Hormone therapy

adverse ocular effects of

178

for breast cancer

712

719

721–723

1670

hormone receptor sites and

716–717

719

720

721–722

1670

1679

in male

727

breast feeding and

786

for cancer prevention

1648–1649

for cancer treatment

1670–1671

for dysfunctional uterine bleeding

729

for erectile dysfunction

951

for female infertility

749

for hypopituitarism

1106–1107

for male infertility

954

for prostate cancer

966

966

1670–1671

Hormones, ectopic production of

by islet cell tumors

1178

in paraneoplastic syndromes

1695

1696–1697

Horner's syndrome (oculosympathetic paralysis)

152

in carotid dissection

458

in cluster headache

977

in coma or stupor

1017

in lung cancer

267

ptosis in

153

stroke causing

993

P.1809

Hospice care

71

Hospital-acquired pneumonia

253–255

Hospitalization

for alcohol use/abuse/withdrawal

1085

1086

for asthma exacerbation

236

for COPD

242

for depression

1068

for diarrhea

546

for head injury

1019

infections acquired during See Nosocomial infections

for opioid overdose/withdrawal

1087

for pelvic inflammatory disease

742

for pneumonia

252

for preeclampsia/eclampsia

772

for psychiatric disorders

1041

psychiatric problems associated with

1095–1097

for schizophrenia/psychotic disorders

1058–1059

for suicidal patient

1067–1068

for third-trimester bleeding

774

for tuberculosis

260

Host defenses, impairment of See Immunocompromised host

Hot environments, disorders caused by exposure to

1592–1595

Hot flushes

estrogen replacement therapy for

1187

in menopause

760

1185

Hot tub folliculitis

118

119

House dust, avoidance therapy for allergies caused by

788–789

Household cleaning agents, poisoning caused by See Caustic/corrosive agents

Howell-Jolly bodies, in sickle cell anemia

493

HPC See Hematopoietic progenitor cell transplantation

HPMPC See Cidofovir

hPMS1/hPMS2 genes, in hereditary nonpolyposis colorectal cancer

636

4-HPR (fenretinide), in cancer prevention

1649–1650

HPV See Human papillomavirus

HRCT See High-resolution computed tomography

HRT (hormone replacement therapy) See Estrogen (hormone) replacement therapy

HSV-1 See Herpes simplex infection, type 1

HSV-2 See Herpes simplex infection, type 2

5-HT₃ receptor antagonists, for chemotherapy-related nausea and vomiting

1682

HTLV See Human T cell lymphotropic/leukemia virus

Humalog See Insulin lispro

Human bite wounds

1296–1297

Human chorionic gonadotropin (hCG)

in amenorrhea, pregnancy and

1183

1184

in ectopic pregnancy

763

770

in gestational trophoblastic disease

774

hyperthyroidism and

774

gynecomastia and

1100

hyperthyroidism during pregnancy and

774

1136

1142

laboratory reference range for

1737

for male infertility

954

1107

pregnancy tests and

763

spontaneous abortion and

768

testicular tumors producing

972

1182

1183

Human diploid cell (HDCV) rabies vaccine

1314

1370–1371

Human granulocytic ehrlichiosis/anaplasmosis

1392

1397

Human growth hormone (somatotropin)

1107

Human herpesvirus 1 and 2 See Herpes simplex infection

Human herpesvirus 3 See Varicella-zoster virus

Human herpesvirus 4 See Epstein-Barr virus

Human herpesvirus 6

1355

1362

aphthous ulcers and

204

Human herpesvirus 7

1355

1362

Human herpesvirus 8 (Kaposi's sarcoma-associated herpes virus)

132

1320

1362

1644

Human herpesviruses

1350–1362

Human IL-1 receptor antagonist See Interleukin-1 (IL-1) receptor antagonist

Human immunodeficiency virus (HIV/HIV-1/HIV-2)

1320

screening blood for antibody to

534

1319

1331

Human insulin

1212

Human interferons See also specific type under Interferon

Human leukocyte antigens (HLA)

800–802

801

disease associations of

800–802

801

typing

800

for granulocyte transfusions

535

for HPC transplant

802

for platelet transfusions

535

for renal transplant

802

913

Human menopausal gonadotropins (hMG), for ovulation induction

750

Human metapneumovirus

1381–1382

Human monocytic ehrlichiosis/anaplasmosis

1392

1396–1397

Human papillomavirus

in anal cancer

648

in cancer etiology

1644

vaccine development and

1700

cancer in HIV infection/AIDS and

1329

in cervical intraepithelial neoplasia/cancer

735

736

screening for

1655

warts caused by

127

anorectal involvement and

645–646

vaginal/vulvar involvement and

732

733

Human parvovirus B19 infection See Parvovirus B19 infection

Human T cell lymphotropic/leukemia virus (HTLV)

1320

1375–1376

myelopathy of

1016

1375–1376

transfusion in transmission of/screening blood for

534

1016

1375

Humanized anti-interleukin-2 receptor antibody

804

Humidifier lung

296

Humoral immunity See also B lymphocytes; Immunoglobulins

infections associated with defects in

1289

Humulin

1212

1213

1215

Hungry bone syndrome

1147

Huntington's disease

1010–1011

1092

genetic/prenatal testing for

1011

parkinsonism differentiated from

1008

H rthle cell thyroid carcinoma

1123

1126

1129

HUS See Hemolytic-uremic syndrome

Hyaline, alcoholic (Mallory bodies/hyalin)

667

Hyaline casts

897

935

Hybridization

comparative genomic, cancer development studied with

1641

in situ, for HER-2/neu assessment in breast cancer

717

Hydatid disease/cysts (hydatidosis)

1513–1515

alveolar (multilocular)

1513

1515

cystic (unilocular)

1513

1513–1515

Hydatidiform mole

773–774

hyperthyroidism in

774

1136

Hydralazine

for cardiac failure

394

for hypertension

437

438

during pregnancy

416

urgencies/emergencies

443

445

nutrients affected by

1260

Hydration See Fluid management/hydration

Hydrocarbon toxicity/abuse

1627

1632–1633

1632

pneumonitis and

294

1632

1633

Hydrocele

933

in filariasis

1522

1523

1524

in testicular cancer

972

Hydrocephalus

in cryptococcal meningitis

1543

intracranial aneurysm causing

996

intracranial mass lesion causing

1002

normal-pressure

1020

Hydrochlorothiazide

428

429

in combination products

430

434

435

Hydrocodone

74

78

Hydrocortisone

1192

1193

for acute adrenal insufficiency

1164

for Addison's disease

1166

for hypopituitarism

1106

topical

87

Hydro-Diuril See Hydrochlorothiazide

Hydrofluoric acid burns

1597

1617

Hydrogen breath test

in irritable bowel syndrome

615–616

in lactase deficiency

606

Hydrogen cyanide gas, poisoning caused by

1623

Hydromorphone

74

77

Hydronephrosis, in tubulointerstitial disease

926

927

Hydrophobia, in rabies

1370

Hydrops

endolymphatic See Endolymphatic hydrops

fetalis

484

485

of gallbladder

687

Hydroquinone, for hyperpigmentation

143

Hydrothorax, hepatic

671

b-Hydroxybutyrate/hydroxybutyric acid

in alcoholic ketoacidosis

888

in diabetic ketoacidosis

887

888

1229

Hydroxychloroquine

for lupus erythematosus

105

835

for malaria chemoprophylaxis/treatment

1496

for rheumatoid arthritis

832

18-Hydroxycorticosterone, in hyperaldosteronism

1173

5-Hydroxyindoleacetic acid (5-HIAA)

in carcinoid syndrome

1692

laboratory reference range for

1739

11-Hydroxylase/P450c11 deficiency

1170

1173

1183

17-Hydroxylase/P450c17 deficiency

1173

1183

P.1810

21-Hydroxylase/P450c21 deficiency

1165

1170

1171

1183

Hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors See Statin drugs

17-Hydroxyprogesterone, in amenorrhea

1183

3b-Hydroxysteroid dehydrogenase deficiency, amenorrhea in

1183

17b-Hydroxysteroid dehydrogenase-3 deficiency

1171

11b-Hydroxysteroid dehydrogenase, in licorice-induced hypokalemia

874

1173

5-Hydroxytryptamine-3 receptor antagonists, for chemotherapy-related nausea and vomiting

1682

Hydroxyurea

in cancer chemotherapy

1675

for essential thrombocytosis

502

for sickle cell disease

494

25-Hydroxyvitamin D₃ See Calcifediol

Hydroxyzine

789

1045

for insomnia

1045

1080

for pruritus

91

Hygroton See Chlorthalidone

Hylorel See Guanadrel

Hymen

imperforate, amenorrhea caused by

1183

remnants of, painful intercourse caused by

747

748

Hymenolepis

diminuta (rodent tapeworm)

1508

1509

nana (dwarf tapeworm)

1508

1509

Hyoscyamine, for irritable bowel syndrome

617

Hyoscyamus niger, toxicity of

1620

Hypaque enema See Diatrizoate meglumine (Hypaque) enema

Hyperacusis

189–190

Hyperadrenergic syndrome, in mitral valve prolapse

331

Hyperaldosteronism

1172–1174

glucocorticoid-remediable

874

hypernatremia and

871

hypertension and

423

1172–1173

1173

hypokalemia and

874

874

1172

1173

saline-unresponsive metabolic alkalosis and

892

Hyperalimentation See Central vein nutritional support

Hyperandrogenism

acne and

115

amenorrhea caused by

1183

1184

in hirsutism/virilization

1170

1171

Hyperbaric oxygen therapy

for acute high-altitude encephalopathy

1605

for acute high-altitude pulmonary edema

1604

for acute mountain sickness

1604

for carbon monoxide poisoning

1611

1621

for clostridial myonecrosis (gas gangrene)

1409

for decompression/dysbaric illness

1603

Hyperbilirubinemia

649

650

651

in biliary tract carcinoma

693

in choledocholithiasis/cholangitis

689

Hypercalcemia

878–880

879

in Addison's disease

1152

1166

cancer-related

267

879

1152

1153

1690–1691

1695

1696

differential diagnosis of

1152–1153

familial hypocalciuric

874

1151

1152

hypercalciuria and

879

944

1150

hyperparathyroidism and

879

1150

1150–1151

1151

in multiple endocrine neoplasia

1191

hypertension and

424

in hyperthyroidism

1152

lithium use and

1076

mental status changes and

1103

in renal failure/dialysis patients

880

908

in sarcoidosis

279

1152

Hypercalciuria

944

944

945

hypercalcemia and

879

944

1150

in hyperparathyroidism

944

945

1150

with hypocalcemia

1147

1148

with hypomagnesemia

874

in hypoparathyroidism treatment

1149

in sarcoidosis

279

Hypercapnia See Respiratory acidosis

Hypercarotenosis

1100

1276

Hyperchloremic normal anion gap acidosis

888–890

889

891

alcoholic ketoacidosis and

888

diabetic ketoacidosis and

887–888

1231

parenteral nutritional support and

890

1284

renal disease/renal tubular acidosis and

888

926

urinary anion gap in assessment of

890

Hypercholesterolemia

clinical presentations in

1243–1244

familial

1241

heart disease risk and

339

340

1240–1241

1241–1242

management of See also Lipid-lowering therapy

in heart disease prevention

341

in nephrotic syndrome

920

921

screening for

1244–1247

1245–1246

Hyperchylomicronemia

1243–1244

familial

1241

Hypercoagulability

531–533

531

in antiphospholipid antibody syndrome

837–838

deep venous thrombosis/pulmonary embolism and

281

470

in nephrotic syndrome

921

in noncirrhotic portal hypertension

680

in paroxysmal nocturnal hemoglobinuria

491

Hypercortisolism

1167–1170

Hyperemesis gravidarum

767

Hypergammaglobulinemia

in bronchiectasis

243

chronic pancreatitis and

697

Hypergastrinemia

carcinoid tumors and

599

in pernicious anemia gastritis

585

in Zollinger-Ellison syndrome (gastrinoma)

595

596

1178

Hyperglycemia See also Diabetes mellitus

alcoholic ketoacidosis and

888

antipsychotic drug use and

1062

coma and See Hyperglycemic (diabetic) coma

control of See Glycemic control in diabetes

in diabetic ketoacidosis

887

1228–1229

1228

differential diagnosis of

1201

1201

drugs causing

1201

in hyperglycemic hyperosmolar state

1228

1231–1232

hypernatremia and

871

hypertonic hyponatremia and

867

insulin action affected by

1196

in pancreatic and periampullary carcinoma

700

in pancreatitis

1201

parenteral nutritional support and

1284

prebreakfast

1218–1219

1219

in pregnancy, congenital anomalies caused by

777

secondary causes of

1201

1201

treatment of See Antidiabetic agents, oral; Insulin therapy

Hyperglycemic (diabetic) coma

1198

in diabetic ketoacidosis

1227–1231

1228

in hyperglycemic hyperosmolar state

1228

1231–1232

lactic acidosis and

1228

1233

Hyperglycemic hyperosmolar state

1228

1231–1232

Hyperhomocysteinemia, in coronary heart disease/occlusive arterial disease

10–11

341

1706–1707

Hypericin/Hypericum perforatum (St. John's wort)

1711–1714

1713

Hyperinfection syndrome, in strongyloidiasis

1529

1530

Hyperinsulinemia

hypoglycemic

insulinoma causing

1235

islet hyperplasia causing (noninsulinoma pancreatogenous hypoglycemia syndrome)

1237

in insulin resistance syndrome (syndrome X)

1197–1198

Hyperkalemia

875–876

875

877

in acidosis

875

889

adrenocortical insufficiency/Addison's disease and

876

1163

1164

in diabetic ketoacidosis

875

1230

genetic disorders associated with

874

in HIV infection/AIDS

876

in hyperglycemic hyperosmolar state

1232

in renal failure

901

908–909

in tubulointerstitial disease

926

Hyperkalemic hyperchloremic acidosis

889

Hyperkalemic periodic paralysis

874

1037

Hyperkeratosis, plantar, of heels

129

Hyperketonemia

in diabetic ketoacidosis

887

1228

1228

at end of life

82

Hyperleukocytosis, in acute leukemia

508

Hyperlipidemia

antipsychotic drugs and

1062

1063

in diabetes mellitus

1201

1243

1244

familial combined

1241

garlic for

1714–1715

isotonic hyponatremia and

866–867

in nephrotic syndrome

920

921

1244

protease inhibitors causing

1340

treatment of See Lipid-lowering therapy

Hypermagnesemia

884

in acute tubular necrosis

904

Hypermetabolism

in burn injury

1598

in HIV infection/AIDS

1322

in pheochromocytoma

1175

Hypermethioninemia, newborn screening for, in homocystinuria diagnosis

1706

Hypernatremia

871–872

dehydration and

871

in enteral nutritional support

1283

in diabetes insipidus

871

1109

1110

in diabetes mellitus/hyperglycemia

871

Hyperopia

153

Hyperosmolality (hyperosmolar disorders)

872

in diabetic ketoacidosis

1229

hyperglycemia and (hyperglycemic hyperosmolar state)

1228

1231–1232

P.1811

Hyperosmolar nonketotic dehydration, parenteral nutritional support and

1284

Hyperostosis, ankylosing (diffuse idiopathic skeletal/DISH)

853

Hyperoxaluric calcium nephrolithiasis

946

Hyperparathyroidism

1149–1155

1150

bone pain in

1102

hypercalcemia and

879

1150

1150–1151

1151

hypercalciuria and

944

945

lithium use and

1076

in multiple endocrine neoplasia

1150

1191

1192

after parathyroidectomy

1153

parathyroidectomy for

1153

in renal failure

911

bone changes and

911

1150

Hyperpathia

intracranial mass lesions causing

1001

stroke causing

991

Hyperphosphatemia

882–883

882

in lactic acidosis

1233

parenteral nutritional support and

1284

in renal failure

882

883

901

acute tubular necrosis

904

hypocalcemia/hyperparathyroidism and

878

883

901

Hyperpigmentation

143

1100

in Addison's disease

143

1100

1165

in alkaptonuria

1704

Berloque

143

busulfan-induced

1684

drugs causing

143

148

1100

chemotherapy agents and

1683

endocrine causes of

1100

nail, drugs causing

145

149

1100

in porphyria cutanea tarda

112

postinflammatory

143

Hyperprolactinemia

1113–1115

1113

amenorrhea and

1114

1184

1185

gynecomastia and

1100

hypogonadotropic hypogonadism and

1106

1113

1179

nipple discharge in

704

risperidone-induced

1060

Hyperproteinemia, isotonic hyponatremia and

866–867

Hyperreactio luteinalis

1171

Hypersensitivity, visceral

chest pain and

581

irritable bowel syndrome and

615

Hypersensitivity pneumonitis

296–297

296

Hypersensitivity reactions See also Allergies/allergic reactions

to drugs See Drug allergy

in HIV infection/AIDS

1320

in nutritional assessment

1263

in schistosomiasis

1502

testing for

1315–1316

Hypersomnias

1080

Hyperstat See Diazoxide

Hypertension

419–445

aortic dissection and

425

451

atherosclerosis and

425

atrial fibrillation and

375

375

cardiac failure and

387

424–425

440

cardiovascular disease/risk factors and

424–425

441

cerebrovascular disease and

425

classification of

419–424

420

in coarctation of aorta

319

320

complications of untreated disease and

424–425

contraceptive-related

424

in Cushing's syndrome

423

1169

1171

dementia and

425

in diabetes mellitus/diabetic nephropathy

423

425

439–440

1222

ACE inhibitors for

425

433

440

440

923

1203–1205

1205

1222

antihypertensive therapy regimens for

439

439–440

440

1203–1205

1205

1222

1225

benefits of control of

423

425

439–440

923

1204–1205

1222

in elderly

54–55

estrogen use and

424

fibromuscular dysplasia/renal artery stenosis and

423

460

464

913

in glomerulonephritis

906

915

headache and

32

425

in heart disease

314

424–425

hyperaldosteronism and

423

1172–1173

1173

intracerebral hemorrhage and

425

994

intracranial See Intracranial hypertension

intraocular See Intraocular hypertension

malignant

442

headache in

32

management of

420

in blacks

440–441

in diabetic patients

439

439–440

440

1203–1205

1222

in elderly

54–55

65

heart disease prevention and

11–12

lifestyle modifications/nonpharmacologic therapy and

419

420

421

421

426–427

pharmacologic

421

427–441

428–432

434–435

436

438

440

developing regimen for

421

437–439

follow-up and

441

general principles of

427–428

goals of

427

427

patient selection for

420

427

427

for urgencies/emergencies

442–445

443–444

preoperative

40–41

metabolic syndrome (syndrome X/CHAOS) and

422

oral contraceptive use and

424

753

in pheochromocytoma

423–424

425

1174

1176

in poisoning/drug overdose

1609

in polycystic kidney disease

928

portal See Portal hypertension

during pregnancy

416–417

424

771–773

772

779

preoperative evaluation/management of patient with

40–41

prevention of

11–12

in elderly

54–55

exercise/activity in

12

421

422

426

primary (essential)

419–422

in pregnancy

779

pulmonary See Pulmonary hypertension

renal disease caused by

425

renal disease causing

422–423

renal failure and

906

907

908

909

renal vascular

423

460

resistant

441–442

442

retinochoroidopathy in

167–168

secondary

422–424

422

stroke and

425

Hypertensive emergencies

442–445

443–444

monoamine oxidase inhibitors causing

1073

in pheochromocytoma

424

1174

1176

1177

in scleroderma

839

Hypertensive encephalopathy

425

442

Hypertensive nephropathy

425

442

Hypertensive urgencies

442–445

443–444

Hyperthecosis See Polycystic ovary syndrome

Hyperthermia

26–28

27

antipsychotic drugs causing See Neuroleptic malignant syndrome

malignant

1610

in poisoning/drug overdose

1610

monoamine oxidase inhibitor interactions and

1610

1629

regional

as adjunct to radiation therapy

1660

for benign prostatic hyperplasia

961

Hyperthyroidism (thyrotoxicosis)

1135–1143

amiodarone-induced

1136

1137

apathetic

1138

1142

atrial fibrillation in

375

1137

1138

1141–1142

cancer-related

1136

1696

cardiac disorders/failure and

389

1137

1141–1142

complications of

1138

treatment of

1141–1143

differential diagnosis of

1138

eye disease associated with (dysthyroid eye disease)

170

1135

1137

1140

1141

factitious

1135

1138

functioning thyroid carcinoma causing

1124

in gestational trophoblastic disease

774

goiter and

1130

1131

1137

1140–1141

Hashimoto's thyroiditis causing

1136

1141

1144

1146

hypercalcemia in

1152

hyperphagia/weight gain in

1099

iodine-induced (jodbasedow disease)

1135

lipid abnormalities and

1244

mental changes associated with

1103

after parathyroidectomy

1153

periodic paralysis and

1137

1138

1142–1143

pituitary tumor/hyperplasia causing

1135–1136

1138

postpartum

1136

1144

during pregnancy

781

1136

1142

struma ovarii causing

1135

1142

subacute thyroiditis causing

1135

1141

1144

subclinical

1138

1142

thyroid function tests in

1116

1117

1137–1138

toxic adenoma/solitary nodule causing

1135

1140

TSH levels in

1116

1117

weight loss in

1137

Hyperthyroxinemia

1106

Hypertonic hyponatremia

866–867

867

Hypertonic saline, for hyponatremia

870

Hypertrichosis, in porphyria cutanea tarda

112

Hypertriglyceridemia

1244

1252

alcohol use/abuse and

1243

1244

1252

in atherogenesis/coronary heart disease

341

1241–1242

1252

in diabetes mellitus

1201

1243

1244

estrogen replacement therapy and

1188

P.1812

in nephrotic syndrome

920

921

nonalcoholic fatty liver disease and

667

pancreatitis and

695

1252

screening for

1244–1247

Hypertrophic cardiomyopathy See Cardiomyopathy

Hypertrophic gastropathy (M n trier's disease)

585

Hypertrophic pulmonary osteoarthropathy

222

862–863

rheumatoid arthritis differentiated from

829

Hypertrophic subaortic stenosis, idiopathic (IHSS)

402

Hyperuricemia

810

811

811

812

cancer-related/chemotherapy-induced

1691–1692

allopurinol for

1677

1691

1692

in gout

810

811

812

renal failure and

904

908

in transplant patient

814

urinary stone formation and

811

930

946

Hyperuricosuric calcium nephrolithiasis

945–946

Hyperventilation

305

lactic acidosis and

1233

in metabolic acidosis

890

in near drowning victim

1603

neurogenic, in coma or stupor

305

1018

respiratory alkalosis and

893

894

voluntary, for acute mountain sickness

1604

Hyperviscosity syndrome

in myeloma

515

in Waldenstr m's macroglobulinemia

517

518

Hypervitaminosis A

1276

Hypervolemic hypernatremia

872

Hypervolemic hypotonic hyponatremia

867

870

Hyphema

171

Hypnagogic hallucinations, in narcolepsy

1080

Hypnosis/hypnotherapy

for chronic pain disorders

1050–1051

for conversion disorders

1049

Hypoadrenalism See Adrenocortical insufficiency

Hypoalbuminemia

ascites and

559

in hookworm disease

1525

hypocalcemia and

877

in protein-losing enteropathy

614

Hypoaldosteronism

1165

in renal tubular acidosis

889

889

1165

Hypocalcemia

877–878

878

in acute tubular necrosis

904

familial

874

with hypercalciuria

1147

1148

hypoparathyroidism and

877

878

1147

1148

1149

magnesium disturbances and

878

883

mental status changes and

1103

muscle cramps caused by

878

1102

in pancreatitis

694–695

696

878

after parathyroidectomy

1153

in pseudohypoparathyroidism

1147

renal failure and

878

901

tetany and

878

1147

1148

Hypocalciuria

879

Hypocalciuric hypercalcemia

879

familial

874

1151

1152

Hypocapnia See Respiratory alkalosis

Hypochloremia, in respiratory acidosis

893

Hypochlorite, for skin decontamination

1611

1632

Hypocholesterolemic drugs See Lipid-lowering therapy

Hypochondriasis

1048

panic disorder and

1043

Hypocitraturic calcium nephrolithiasis

946

Hypocomplementemia, in lupus erythematosus

105

835

Hypofibrinogenemia, in disseminated intravascular coagulation

530

Hypogammaglobulinemia

in chronic lymphocytic leukemia

510

common variable immunodeficiency causing

796

infections associated with

1289

Hypoglycemia

1220

1233–1239

adrenocortical insufficiency/Addison's disease and

1165

alcoholic ketoacidosis and

888

alcohol-related

1234

1234

1238

alimentary

1234

1234

1238

altered awareness of

1220

in insulinoma

1235

cancer-related

1696

coma/mental status changes caused by

1103

1228

in poisoning/drug overdose

1608

exercise-induced

1217

extrapancreatic tumors causing

1237

factitious

1234

1238–1239

fasting

1233–1234

1234

1234

after ethanol ingestion

1238

in insulinoma diagnosis

1235

functional

1238

glucagon response to, lack of in type 1 diabetes

1220

immunopathologic

1234

1234

1239

insulin-induced

1202

1204

1220

late (occult diabetes)

1234

1238

in malaria (severe P falciparum infection)

1497

pancreatic B cell tumors/insulinoma causing

1178

1234–1237

1234

pentamidine-induced

1239

1542

persistent islet hyperplasia causing (noninsulinoma pancreatogenous hypoglycemic syndrome)

1237

postgastrectomy

1238

postprandial (reactive)

1234

1234

1238

after ethanol ingestion

1238

Hypoglycemic agents See Antidiabetic agents; Insulin therapy

Hypoglycemic unawareness

1220

in insulinoma

1235

Hypogonadism

1104–1105

female

1104

1105

1183

1184

1185–1189

amenorrhea in

1183

1184

premature (premature ovarian failure)

1184–1185

in Turner's syndrome

1183

1184

1189

growth hormone-secreting pituitary tumor causing

1111

in HIV infection/AIDS

1327

hypergonadotropic

1179–1180

1180

1181

in hyperprolactinemia

1106

1114

hypogonadotropic

953

954

1104

1104–1105

1105–1106

1106–1107

1179

1180

1181

male

1104

1105

1179–1182

1180

gynecomastia and

1100

infertility and

953

953

954

sexual dysfunction and

951

1101

mental changes associated with

1103

Hypokalemia

873–875

873

in diabetic ketoacidosis

1230

genetic disorders associated with

874

874

in heat stroke

1595

hyperaldosteronism and

874

874

1172

1173

hypomagnesemia and

883

metabolic alkalosis and

891

892

parenteral nutritional support and

1284

in renal failure

908

renal tubular acidosis and

889

889

Hypokalemic hyperchloremic metabolic acidosis

889

Hypokalemic periodic paralysis

874

1037

in hyperthyroidism

1137

1138

1142–1143

Hypomagnesemia

883–884

883

hypocalcemia/hypoparathyroidism and

878

883

1147

parenteral nutritional support and

1284

Hypomagnesemia-hypercalciuria syndrome

874

Hypomania

1075

in cyclothymic disorders

1067

Hyponatremia

866–871

867

adrenocortical insufficiency/Addison's disease and

869

1163

1164

encephalopathy and

870

endurance exercise causing

869

in HIV infection/AIDS

870–871

in hyperglycemic hyperosmolar state

867

1232

in hypothyroidism

869

1131

1132–1133

idiosyncratic drug reactions causing

869

MDMA use/abuse and

869

1618

mental status changes caused by

1103

mineralocorticoid-responsive, in elderly

869

after pituitary surgery

1106

polydipsia causing

869

1058

in porphyria

1703

postoperative

869

in syndrome of inappropriate ADH secretion

868–869

868

Hypoparathyroidism

1147–1149

1149

hypocalcemia and

877

878

1147

1148

after parathyroid surgery

1147

Riedel's thyroiditis causing

1145

tetany and

878

1147

1148

after thyroidectomy

1125

1126

1140

1147

Hypoperfusion, end organ, in shock/impending shock

478

Hypophosphatasia, osteomalacia in

1160

Hypophosphatemia

880–882

881

in diabetic ketoacidosis

1230–1231

in hyperglycemic hyperosmolar state

1232

osteomalacia/rickets and

874

1159

1161

Hypophysectomy, for breast cancer

722

Hypopigmentation

143–144

endocrine causes of

1100

in tuberous sclerosis

1006

Hypopituitarism

amenorrhea and

1183

1184

1185

anterior

1104–1108

mental status changes and

1103

posterior

1108–1110

Hypopnea See Apnea

Hypoprothrombinemia, in cirrhosis

673

Hypopyon

153

in anterior uveitis

162

in bacterial keratitis

158

Hyporeninemic hypoaldosteronemic renal tubular acidosis

889

889

891

1165

Hypospadias

933

Hypotension

477–480

ACE inhibitors causing

391

in Addison's disease

1165

bleomycin-induced

1685

in desensitization therapy

1316

in diabetes mellitus

1198

P.1813

dysautonomia (autonomic dysfunction) and

987

myocardial infarction and

363

orthostatic (postural) See Orthostatic (postural) hypotension

after pheochromocytoma removal

1177

in poisoning/drug overdose

1608–1609

right ventricular infarction and

363–364

in shock/impending shock

478

syncope and

384

transient ischemic attacks and

989

Hypotensive agents See Antihypertensive drug therapy

Hypothalamus

disorders of

1103–1115

amenorrhea caused by

1183

1184

obesity in

1099

1106

pituitary gland regulation and

1103–1104

Hypothermia

drowning and

1602

1603

of extremities

1591

in poisoning/drug overdose

1608

rhabdomyolysis and

843

systemic (accidental)

1589–1591

Hypothyroidism

1105

1106

1131–1135

amiodarone-induced

1131

1133

1136

cardiac disorders/failure and

389

1132

cretinism and

1103

fetal, maternal hyperthyroidism and

1131

1142

fibromyalgia in

821

goiter and

1130

1131

Hashimoto's thyroiditis and

1144

1146

after hyperthyroidism treatment

1139

1140

hyponatremia in

869

1131

1132–1133

lipid abnormalities and

1243

1244

lithium causing

1076

mental status changes in

1103

postpartum

1136

1144

during pregnancy

781

1133–1134

preoperative evaluation/management of patient with

46

Riedel's thyroiditis causing

1145

Schmidt's syndrome and

1144

1165

1201

subacute (deQuervain's) thyroiditis causing

1131

1144

thyroid function tests in

1117

1117

1132

after thyroidectomy

1125

1126

TSH deficiency/levels in

1105

1106

1117

1117

1131

1132

1134

weight gain in

1099

1132

weight loss in

1132

Hypotonic hyponatremia

867–870

867

Hypoventilation

alveolar

central

305

in chronic mountain sickness (Monge's disease)

1605

primary (Ondine's curse)

304–305

obesity and (Pickwickian syndrome)

305

Hypovolemic hypernatremia

872

Hypovolemic hypotonic hyponatremia

867

868

Hypovolemic shock

477

in myocardial infarction

363

Hypoxemia

in ARDS

309

310

in asthma

228

236

237

in COPD

238

242

home oxygen therapy and

240–241

240

dyspnea and

218

in interstitial (diffuse parenchymal) lung disease

275

in malignant pleural effusion

302

in near drowning victim

1602

in respiratory failure

308

Hypoxia

air travel and

1606

chronic, in Monge's disease

1605

in heart disease

312

at high altitude

1604

lactic acidosis and

887

in near drowning victim

1602

in pulmonary embolism

281

Hysterectomy See also Menopause, surgical

antibiotic prophylaxis for

47

for cervical cancer

737

for endometrial carcinoma

739

for endometriosis

741

for ovarian cancer

746

for pelvic inflammatory disease

743

premature ovarian failure and

1185

for uterine leiomyoma

738

for uterine prolapse

741

Hysteria (somatization disorder)

1048

Hysterical conversion (conversion disorder)

1048

1049

pseudoseizures and

983

1048

Hysterical (histrionic) personality disorder

1055

Hysterosalpingography

729

749

Hysteroscopy

729

in abnormal premenopausal bleeding

728–729

Hytakerol See Dihydrotachysterol

Hytrin See Terazosin

Hyzaar See Losartan, with hydrochlorothiazide

¹²³I

for mIBG in pheochromocytoma diagnosis

1176

for thyroid scanning

1117

1118

for whole body scanning, in thyroid cancer surveillance

1127–1128

¹²⁵I-iothalamate scanning, in renal function evaluation

899

¹³¹I

for goiter

1131

for Graves' disease/hyperthyroidism

1139–1140

ophthalmopathy flares and

1140

1141

for thyroid cancer treatment

1126–1127

for thyroid scanning

1118

for whole body scanning, in thyroid cancer surveillance

1127–1128

¹³¹I mIBG, in pheochromocytoma diagnosis

1176

¹³¹I-orthoiodohippurate scanning, in renal function evaluation

899

¹³¹I Tositumomab See Tositumomab